91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In Dr Tanja Obradovic's article in The Cancer Letter, she discusses how to navigate early clinical development and support robust registrational strategy and late-stage development in oncology.
-
In this article, 91黑料’s Andreas Dreps and Martin Lachs discuss how the success of mRNA-based vaccines paves the way for mRNA in oncology and beyond.
-
In this article in Clinical Research News, Alyssa Gilliam, Vice President, CSM & IRT and Chad Crafford, Clinical Supplies Manager outline practical considerations for managing your CGT supply chain to minimise risk, mitigate cost and complexity.
-
In this article, 91黑料’s Andreas Dreps and Martin Lachs discuss the logistical considerations in
?BioPharm International
-
Learn more about the in this article.
? Huber, B.; Joeckel, T. Challenges of Expanding CAR-T Cell Therapy into Solid Tumors. BioPharm International 2023, 36 (5), 22–23,27
-
In this article,Brian HuberandTamie Joeckel,
-
Tim Clark, VP Drug Development Solutions and Alan Phillips, Sr. Director Biostatistics present a case study on the first in human Bayesian Optimal Interval design.
-
Brandon Fletcher, Principal, Cell and Gene Therapy, offers his insights on .
-
Tim Clark, VP Drug Development Solutions, Martin Lachs, VP Project Management Oncology & Cell Therapeutics and Alan Phillips, Sr. Director Biostatistics, offer insights on .
-
Cindy Spittle shares insights on the growth of molecular diagnostic testing in clinical trials.
